Valmark Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6M Sell
23,608
-97
-0.4% -$22.6K 0.06% 139
2026
Q1
$5.79M Sell
23,705
-122
-0.5% -$28.4K 0.07% 122
2025
Q4
$4.93M Sell
23,827
-120
-0.5% -$23.7K 0.06% 135
2025
Q3
$4.44M Buy
23,947
+466
+2% +$79.8K 0.06% 136
2025
Q2
$3.59M Sell
23,481
-80
-0.3% -$12.3K 0.05% 150
2025
Q1
$3.91M Sell
23,561
-358
-1% -$56K 0.06% 131
2024
Q4
$3.46M Sell
23,919
-1,121
-4% -$174K 0.05% 135
2024
Q3
$4.06M Buy
25,040
+338
+1% +$53.9K 0.06% 122
2024
Q2
$3.61M Sell
24,702
-129
-0.5% -$19.2K 0.06% 124
2024
Q1
$3.93M Sell
24,831
-210
-0.8% -$33.4K 0.07% 114
2023
Q4
$3.92M Sell
25,041
-97
-0.4% -$14.9K 0.07% 106
2023
Q3
$3.92M Buy
25,138
+1,122
+5% +$185K 0.08% 93
2023
Q2
$3.98M Buy
24,016
+28
+0.1% +$4.52K 0.08% 92
2023
Q1
$3.72M Sell
23,988
-17
-0.1% -$2.75K 0.08% 87
2022
Q4
$4.24M Buy
24,005
+896
+4% +$155K 0.1% 78
2022
Q3
$3.77M Buy
23,109
+234
+1% +$39.6K 0.08% 73
2022
Q2
$4.06M Sell
22,875
-426
-2% -$75.9K 0.08% 71
2022
Q1
$4.13M Buy
23,301
+908
+4% +$155K 0.07% 78
2021
Q4
$3.83M Sell
22,393
-533
-2% -$87.3K 0.07% 79
2021
Q3
$3.7M Sell
22,926
-443
-2% -$75.6K 0.07% 77
2021
Q2
$3.85M Buy
23,369
+724
+3% +$120K 0.07% 75
2021
Q1
$3.72M Buy
22,645
+3,354
+17% +$543K 0.07% 69
2020
Q4
$3.04M Buy
19,291
+12,433
+181% +$1.83M 0.06% 78
2020
Q3
$1.02M Sell
6,858
-89
-1% -$13.2K 0.02% 131
2020
Q2
$977K Buy
6,947
+158
+2% +$23K 0.02% 118
2020
Q1
$890K Buy
6,789
+657
+11% +$93.2K 0.02% 104
2019
Q4
$895K Sell
6,132
-895
-13% -$121K 0.02% 105
2019
Q3
$909K Buy
7,027
+730
+12% +$96.2K 0.02% 108
2019
Q2
$877K Sell
6,297
-78
-1% -$10.8K 0.02% 104
2019
Q1
$891K Sell
6,375
-33
-0.5% -$4.42K 0.02% 100
2018
Q4
$827K Buy
6,408
+130
+2% +$18.1K 0.02% 98
2018
Q3
$867K Sell
6,278
-43
-0.7% -$5.71K 0.02% 96
2018
Q2
$767K Buy
6,321
+610
+11% +$76.1K 0.02% 98
2018
Q1
$732K Sell
5,711
-77
-1% -$10.4K 0.02% 96
2017
Q4
$809K Buy
+5,788
New +$806K 0.02% 86
2016
Q1
Sell
-2,400
Closed -$247K 71
2015
Q4
$247K Buy
+2,400
New +$241K 0.01% 60

Other funds holding JNJ

Valmark Advisers's JNJ Position: Q2 2026 in Review

Valmark Advisers reduced its Johnson & Johnson (JNJ) stake by 0.41% in Q2 2026, selling an estimated $22.6K and leaving 23,608 shares worth $6M. The position accounts for 0.06% of the portfolio, ranked #139.

Valmark Advisers first reported a position in JNJ in Q4 2015 and has held it in 36 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Valmark Advisers held 23,608 shares of Johnson & Johnson worth $6M as of Q2 2026.
  • Valmark Advisers sold 97 Johnson & Johnson shares in Q2 2026, an estimated $22.6K.
  • Johnson & Johnson made up 0.06% of Valmark Advisers's portfolio in Q2 2026, its #139 holding.
  • Valmark Advisers first reported a position in Johnson & Johnson in Q4 2015 and has held it in 36 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.